Contact this trialFirst, we need to learn more about you.
GLP-1 Receptor Agonist
Tirzepatide for Type 2 Diabetes and Obesity
Recruiting0 awardsPhase 2
Sacramento, California
This trial aims to see how safe and effective different doses of tirzepatide are for people with Type 2 diabetes and obesity who are already on metformin. The study will go on
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.